Head and neck sarcomas: A single institute series

Area of Science:

• Oncology
• Surgical Pathology
• Medical Research

Background:

• Sarcomas are rare malignancies originating from mesenchymal tissues, comprising approximately 1% of all cancer diagnoses.
• Understanding the distinct biological behavior and treatment of sarcomas is crucial for improving patient outcomes.

Purpose of the Study:

• To retrospectively analyze treatment patterns and outcomes for head and neck sarcomas.
• To compare craniofacial bone sarcomas (BSs) and soft tissue sarcomas (STSs) within this cohort.
• To identify distinct surgical clearance principles based on sarcoma origin.

Main Methods:

• Retrospective analysis of 107 head and neck sarcoma cases treated over 13 years.
• Categorization into bone sarcomas (BSs) and soft tissue sarcomas (STSs).
• Review of treatment modalities (chemotherapy, surgery, radiotherapy) and survival data.

Main Results:

• The cohort included 54 BSs (predominantly high-grade osteosarcoma) and 53 STSs (rhabdomyosarcomas, myxofibrosarcomas most common).
• BSs typically received neoadjuvant chemotherapy followed by surgery; STSs were primarily treated with surgery and radiotherapy.
• Overall survival was 79% at 2 years and 64% at 5 years, with a mean follow-up of 48 months.

Conclusions:

• Head and neck sarcomas, including BSs and STSs, exhibit diverse histological types and require tailored treatment strategies.
• Distinct surgical principles are necessary for sarcomas due to their mesenchymal origin and patterns of spread.
• The study underscores the importance of individualized treatment approaches for optimizing survival in head and neck sarcoma patients.